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ABSTRACT
Objective: Inflammatory bowel diseases are idiopathic inflammatory disorders of the gastrointestinal tract. Chronic inflammation that occurs in the 
colon can develop into colon cancer. Lunasin has been known to resist inflammatory reactions induced by lipopolysaccharide in vitro. The role of 
lunasin as anti-inflammatory in vivo is not widely known. In this study, we analyzed the effect of lunasin from Indonesian soybean to decrease the risk 
of inflammation by analyzing the expressions of inducible nitric oxide synthase (iNOS) and β-catenin.
Methods: A total of 30 mice are divided into six groups. Normal group was not induced by dextran sodium sulfate (DSS). The other groups were 
induced by DSS 2% through drinking water for 9 days. After 9 days, negative group did not receive any treatment, besides the other groups received 
treatment given lunasin dose 20 mg/kg BB and 40 mg/kg BB, commercial lunasin, and positive given aspirin. Treatment was performed for 5 weeks. 
Immunohistochemistry scores of iNOS and β-catenin proteins were analyzed using statistical tests.
Results: Expression of iNOs decreased significantly (p<0.05) with an average score of 60.134 and 35.473. Expression of β-catenin decreased 
significantly (p<0.05) with an average score of 15.58 and 11.131.
Conclusion: Lunasin dose 20 mg/kg BW and 40 mg/kg BB were able to inhibit inflammation by decreasing the expressions of iNOS, and β-catenin.
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INTRODUCTION
Inflammatory bowel disease (IBD) is a condition that describes chronic 
inflammation of the gastrointestinal tract that can be divided into two 
major disorders, namely, ulcerative colitis (UC) and Crohn’s disease 
(CD) [1]. Both types of this disease are distinguished based on the 
location of the inflammation [2]. In UC disease, inflammation occurs 
only in the colon. While CD, inflammation can occur in all parts of the 
digestive tract from mouth to anus [1].
The first highest incidence of IBD cases occurs in patients with an 
age range between 15 and 30 years. The second highest incidence 
occurred between the ages of 50 and 80 years. The prevalence of IBD 
is higher in the western states than in developing countries [1]. About 
1-2 million people in the United States are estimated to have either 
UC or CD, with insects ranging from 70 to 150 cases per 100,000 
individuals. Whereas in Europe, the incidence of UC ranges from 7.3 
cases per 100,000 population and CD incidence is about 5.8 cases per 
100,000 population [3].
IBD can develop into colon cancer known as colitis-associated cancer 
(CAC). This cancer is usually difficult to treat, thus increasing the 
mortality rate [4]. A study reported more than 20% of IBD patients can 
develop into colon cancer and 50% of patients die of colon cancer [5]. 
These patients reported increased gene expression that contributed 
to the inflammatory process [6]. Patients with a potentially higher UC 
develop into colon cancer compared to CD patients. Increased risk of 
IBD into colon cancer also occurs in IBD patients who have a family 
history of colon cancer [7].
The increased risk of IBD for developing CAC depends on the duration 
and extent of inflammation [1]. Area of inflammation can be driven by 
the accumulation of immune cells and inflammatory mediators such as 
cytokines, chemokines, growth factors, lipid molecules, reactive oxygen 
species (ROS), and nitrogen species. The interactions between immune 
cells, inflammation and cytokines lead to signal stimulation that helps 
the development, growth, and metastases of tumor cells. A clear link 
exists between inflammation (IBD) and colon cancer [4].
Inflammation in the epithelial cells of the colon can lead to the formation 
of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 
(COX-2), which resulted in upregulation of the production of nitric 
oxide (NO) and prostaglandin E2 (PGE2). Both of these molecules cause 
an increased ROS. ROS can cause a variety of damage to protooncogene 
and tumor suppressor gene. The damages caused by ROS stimulate 
gene expression in normal epithelial cells into cells preneoplastic and 
neoplastic cells [8]. β-catenin is one protooncogene associated with 
cancer development colon cancer [9]. Mutations of β-catenin gene 
result in β-catenin protein overexpression in cytoplasm and nuclear 
of colorectal crypt epithelial cell [10]. Inflammation models can be 
obtained by induction of dextran sodium sulfate (DSS) as a compound 
that stimulates inflammation [11,12].
One of the utilization of natural ingredients that are known to have anti-
inflammatory effect is soybean. An agent that had been identified in 
soybean is lunasin [13-15]. Lunasin peptide also can be found in wheat 
and dairy products such as soy milk, tofu, tempeh, whole wheat bread, 
and others [14,15].
In vitro studies have demonstrated the effect of lunasin to suppress 
inflammatory reactions induced by lipopolysaccharide (LPS). The 
ability of lunasin in suppressing the inflammatory activity thought 
to be used as a deterrent to the development of colon cancer-related 
inflammation. Some studies indicate lunasin have the potential 
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to reduce the production of proinflammatory cytokines such as 
interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) as well as 
proinflammatory mediators, such as PGE2, through modulation of 
COX-2/PGE2 and iNOS/NO pathway by inhibiting NF-κB pathway in 
RAW 264 macrophage cells induced by LPS [16-18].
The role of lunasin as an anti-inflammatory in vivo is not widely known. 
Research on the expression of β-catenin as a result of the regulation of 
iNOS in colorectal epithelial cells of mice is expected to provide some 
information regarding the effect of lunasin on the expression of three 
proteins to inhibit inflammation and potentially reduce the risk of colon 
cancer, particularly those initiated by inflammation (IBD).
METHODS
Plant material and extraction
Soybean was obtained from Indonesian Legumes and Tuber Crops 
Research Institute Malang of East Java, Indonesia. Soybean variety used 
in this study was Grobogan because it contents the highest protein than 
other varieties (to reach 43.9%).
Soybean seed was pressed to obtain free oil defatted soybean. The 
defatted soybean Grobogan was macerated with aquadestilated 
(1:5, 30 min) and filtrated 3 times. Filtrate was dried with rotary vapor 
resulted soybean extract. The result was tested by high-performance 
liquid chromatography (HPLC) to determine the content of lunasin 
according to previous study [19].
HPLC analysis of lunasin
Analysis of lunasin in extract was tested by HPLC. 100 mg extract is 
dissolved in 8 mL of aquadest, then the solution is dismonicated for 
30 min and then added aquadest up to 10 mL (10.000 ppm solution). The 
solution was then centrifuged at 12,000 rpm for 30 min and the filtrate 
was filtered with a 0.22 μm millipore filter and obtained a clear and 
colorless solution. The solution was determined lunasin levels by HPLC 
method using C18 column and UV-Vis detector, using acetonitrile-water 
phase: Water at 5:95 ratio, retention time 35 min, wavelength 295 nm, 
injection volume 20 μL, and motion phase velocity 2 mL/min [19].
Commercial lunasin
Commercial lunasin was produced by Reliv Internatioal Inc. USA and 
imported by PT. Reliv Indonesia. Commercial lunasin used in this 
research is the most pure, concentrated form of lunasin ever produced. 
It contents 125 grams of high-quality soy protein.
Animal
A total of 30 male Swiss–Webster mice (8-10 weeks) with an average 
weight of 20 g were supplied by the Health Research and Development 
Agency of the Ministry of Health of the Republic of Indonesia. The mice 
were kept in independent ventilation cages (48 cm × 35 cm × 20 cm) 
with free access to food and water under controlled humidity (55±5%), 
light/dark cycle (12/12 h), and temperature (23±1°C). The mice were 
carefully examined to ensure that they are in healthy conditions and 
acclimatized for 1 week before any experimental procedure was 
performed. All protocols and surgical procedures were approved by 
the animal care and use committee of the faculty of medicine of the 
University of Indonesia.
Induction of inflammation
Induction of inflammation procedure was adopted from Perse et al.: 
Mice were given DSS 2% drinking water for 9 days [12].
Experimental groups
A total of 30 mice were randomized into the following six groups: 5 mice 
in normal group; 5 mice in negative group, only received induction 
2% DSS for 9 days; 5 mice positive group received a daily oral aspirin 
suspension at a dose of 42,25 mg/kgBW after 9 days induction; 5 mice 
received and SE2 a daily oral soybean extract contained lunasin at a dose 
of 20 and 40 mg/kgBW after 9 days induction; respectively; commercial 
lunasin treatment groups (CL), which received daily oral commercial 
lunasin at a dose of 16,25 mg/kgBW, after 9 days induction. After 
5 weeks, the mice were sacrificed, and colon tissues of mice were taken.
Tissue sample preparation
Colon tissues of mice were cleaned from the lumen of the colon with 
water. Tissues were fixed with 10% of buffered neutral formalin and 
embedded in paraffin blocks.
Immunohistochemistry staining
Tissue sample was cut to a thickness of 3-5 μm for immunohistochemistry 
staining. The specimens were deparaffinized with Xylol I, II, and 
III for 5 minutes each, then rehydrated with absolute alcohol, 90% 
alcohol and 70% alcohol for 5 minutes each. After deparaffination 
and rehydration, specimens were spilled by 0.5% of H2O2 to eliminate 
endogenous peroxide for 30 min at room temperature. To block non-
specific antigen sites, specimens were incubated for 10 min in tris-
EDTA at 96oC temperature. Specimens were incubated with rabbit 
polyclonal antibodies of iNOS (1:100 dilution) or rabbit polyclonal 
β-catenin (1:300 dilution) for 1 hours at room temperature. Specimens 
were then incubated with the appropriate secondary antibody for 
15 minutes, followed by incubation with HRP-conjugated streptavidin 
for 15 minutes. Proteins visualized using 3,3’ diaminobenzidine for 
2 min. The specimens were added counterstain with hematoxyllin, 
dehydrated, clearing, and mounting.
Evaluation of immunohistochemistry staining
iNOS expressions in the cytoplasm and β-catenin expressions in the 
nuclear of colon crypt epithelial cells were scored semiquantitatively 
using H-score assessment at ×400 magnification. The total number of 
cells in each field and the number of cells stained at each intensity were 
counted. The average percent positive was calculated and the following 
formula [20]:
S = (SSS × SP) + (ISS × IP) + (WSS × WP) + (NSS × NP)
S: Total score,
SSS: Strong staining score (3),
SP: Strong percentage (0-100%),
ISS: Intermediate staining score (2),
IP: Intermediate percentage (0-100%),
WSS: Weak staining score (1),
WP: Weak percentage (0-100%),
NSS: Negative staining score (0),
NP: Negative percentage (0-100%).
Statistical analysis
The average total scores are reported as the mean rank. Since the 
total score was not normally distributed, the association between 
immunohistochemistry score was analyzed using the Mann–Whitney 
test or Kruskal–Wallis one-way analysis of variance by ranks. p<0.05 
was considered statistically significant. Statistical analysis was 
performed using SPSS 20.0 statistical package.
RESULTS
HPLC analysis of lunasin
HPLC analysis of lunasin from Grobogan soybean was showed in 
Fig. 1 [19].
Lunasin content of Grobogan soybean extract
Lunasin content of the Grobogan soybean extract was measured in 
duplo, shown in Table 1, following previous studies [19].
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Effect of soybean extracts administration on iNOS expression
Induction of DSS 2% can increase expression of iNOS in negative group 
which is significantly different from the normal group (p=0.29). Mann–
Whitney test shows statistically significant difference between the 
negative control group and SE1 group (p=0.29), SE2 group (p=0.29), 
and CL group (p=0.29). This shows that expression of iNOS caused 
induction of DSS 2% can be decreased by lunasin in soybean extract. 
Mann–Whitney test does not show statistically significant difference 
in iNOS expression score among the treatment groups. The effect of 
soybean extract administration on the iNOS expression is shown in 
Fig. 2. Expressions of iNOS in a colorectal epithelial cell of mice are 
shown in Fig. 3.
Effect of soybean extracts administration on β-catenin expression
Induction of DSS 2% can increase expression of β-catenin in negative 
group which is significantly different from the normal group (p=0.29). 
Mann–Whitney test shows statistically significant difference between 
the negative control group and SE1 group (p=0.29), SE2 group (p=0.29), 
and CL group (p=0.29). This show that expression of β-catenin caused 
induction of DSS 2% can be decreased by lunasin in soybean extract. 
Mann–Whitney test does not show statistically significant difference in 
β-catenin expression score among the treatment groups. The effect of 
soybean extract administration on the β-catenin expression is shown in 
Fig. 4. Expressions of β-catenin in colorectal crypt epithelial cell of mice 
are shown in Fig. 5.
DISCUSSION
Lunasin is one of the peptides found in soybeans. Previous research 
has proven that lunasin in soybean has various clinical effects such as 
anti-inflammation that is newly proven in vitro [15]. Based on that, this 
research is made to prove the activity of the active compound of lunasin 
in soybean as an anti-inflamatory agent in vivo seen from the expression 
of iNOS, and β-catenin in DSS-induced mice colon depicting IBD disease.
This study used Swiss Webster mice induced DSS to induce colonic 
inflammation. DSS can cause a colitis-like disease condition in a rat 
Table 1: Lunasin content of the Grobogan soybean extract
Sample Lunasin content (mg/g)
Grobogan soybean extract 0.808
0.838
Fig. 1: High-performance liquid chromatography profile of 
lunasin from Grobogan soybean
Fig. 2: Mean inducible nitric oxide synthase (iNOS) expressions 
score of mice crypt epithelial cells after induction of dextran 
sodium sulfate. *p<0.05 = significantly different compared to the 
negative control group. **p>0.05 = no significant difference in 
iNOS expression score among the treatment groups
Fig. 3: Expressions of inducible nitric oxide synthase (iNOS) in colorectal epithelial cell of mice (magnification ×400). (a) Normal group, 
(b) negative group, (c) positive group (Aspirin), (d) SE1 (lunasin 20 mg/kgBW), (e) SE2 (lunasin 40 mg/kgBW), and (f) commercial 
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model. The concentration of DSS and its molecular mass also play the 
vital role in colitis induction. The impact of DSS supplementation on 
colon tissues was assessed by histochemical studies. Both distal and 
proximal regions of the colon were examined with following parameters 
to measure the severity of the disease condition such as loss of epithelial, 
loss of mucosal architecture, mononuclear and polymorphonuclear 
cells in lamina propria, infiltration of inflammatory cells in submucosa, 
cryptitis and abscess formation, erosion or ulceration, and goblet cell 
depletion. This study suggests that DSS 5 KDa can significantly increase 
inflammatory genes IL-6, TNF-α, and iNOS [21].
Immunohistochemistry observations showed the highest expression 
of iNOs in DSS-induced groups. The high expression of iNOS in this 
group can be caused by administration of DSS to induce the expression 
of iNOS [22]. DSS can cause damage to mucosal epithelial barrier 
function and resulting in the entry of bacteria and antigens into the 
colonic mucosa, thus triggering the inflammatory response [23]. In 
the inflammatory reaction, the induced form of NO synthase (iNOS) 
has a considerable role. Inflammatory cells express iNOS in response 
to stimulation of cytokines such as IL-1β and IL-6 in inflammatory 
reactions. The enzyme chains off the production of NO which have a 
pro-inflammatory action vasodilator increases vascular permeability 
and stimulates prostaglandin production [24].
Suzuki et al. [25] showed that expression of nitrotyrosine was higher 
in DSS-induced mice of 2% and 1%. Nitrotyrosine is a marker of the 
reaction between peroxynitrite and tyrosine proteins. Peroxynitrite is 
the result of the reaction of NO with superoxide (O2) [25]. The high 
peroxynitrite showed high NO which proves the existence of iNOS 
as enzymes involved in the production of NO [24]. The results are 
consistent with the observations made in groups of mice induced by 
DSS.
Lunasin with a dose of 20mg/kgBW and 40mg/kgBW on soy extract 
can significantly reduce the expression of iNOs but not better than 
commercial aspirin and lunasin. This is probably due to the purity of 
commercial lunasin better than lunasin contained in soybean extract of 
Grobogan varieties.
Several studies have shown that lunasin has anti-inflammatory effects 
by decreasing the production of NO in the RAW 264.7 cells induced 
by LPS, which plays a role in the pathogenesis inflammation [16,17]. 
NO production decline due to a reduction in iNOS expression in 
inflammatory cells. Thus, lunasin plays a role in decreasing expression 
of iNOs which is one of the markers on the pathogenesis of inflammation. 
Results of other studies report that lunasin purified can decrease 
the expression of iNOS and COX-2 and inhibit the production of pro-
inflammatory cytokines such as TNF-a, Interleukins-1β (IL-1β), and NO 
in the RAW 264.7 cells induced by LPS [26].
There are several secondary metabolite compounds such as flavonoids 
and phenolics present in soybeans that potentially inhibit the expression 
of iNOs. The study reported by Laaboudi et al., mentions that phenolic 
compounds have anti-inflammatory activity [27]. While the study by 
Kazlowska et al., [28] mentions that the expression of iNOS in RAW 
264.7 cells can be inhibited by flavonoid and phenolic compounds thus 
suppressing the production of NO.
In immunohistochemistry observations using β-catenin antibodies, 
the highest expression was in the DSS-induced negative control group 
of mice. The high expression of β-catenin may be due to the high 
production of iNOs in inflammatory conditions. Inflammation in the 
epithelial cells of the colon can lead to the formation of iNOS and COX-2, 
which resulted in upregulation of the production of NO and PGE2. 
Fig. 4: Mean β-catenin expressions score of mice crypt epithelial 
cells after induction of dextran sodium sulfate. *p<0.05 = 
significantly different compared to the negative control group. 
**p>0.05 = no significant difference in β-catenin expression score 
among the treatment groups
Fig. 5: Expressions of β-cateFig. 5: Expressions of β-catenin in colorectal crypt epithelial cell of mice (magnification ×400). (a) Normal 
group, (b) negative group, (c) positive group  nin in colorectal crypt epithelial cell of mice (magnification ×400). (a) Normal group, 
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Both of these molecules cause increased ROS. ROS causes a variety 
of protooncogenic damage and tumor suppressor gene [8]. Damage 
caused by ROS stimulates the development of gene initiation in normal 
epithelial cells into cancer cells [9]. β-catenin is one of the suppressor 
gene tumors associated with the development of colon cancer. Under 
normal conditions, β-catenin is found in cell membranes and slightly in 
the cytoplasm and the nucleus. However, if there is a mutation in APC 
protooncogene, there will be an increase in the amount of β-catenin 
that can accumulate in the cytoplasm into the nucleus of epithelial 
cells kolon [10]. Therefore, in this study, the expression of β-catenin 
observed in the cytoplasm and nucleus that occur on the condition 
dysplasia. Increased β-catenin expression can be found in animals 
with DSS-induced dysplasia conditions and in humans with colitis-
associated colon cancer [28].
Lunasin dose 20 mg/kgBW and 40 mg/kgBW can reduce the expression 
of β-catenin in mice induced by DSS, but not as good as commercial 
lunasin. The activity of lunasin as anti-inflammatory can decrease iNOs 
expression significantly. Decreased expression of iNOS in inflammatory 
cells likely to have a role in reducing the expression of β-catenin.
Lunasin is also known to have antioxidant activity. Lunasin was 
able to suppress the production of ROS in macrophages induced by 
LPS [16]. The decline in ROS production can reduce the damage and 
tumor suppressor gene protooncogene thus potentially reducing 
protooncogene mutations in the APC gene and over-expression on 
β-catenin so accumulated to the nucleus [8].
CONCLUSION
We have demonstrated that the administration of lunasin in the form 
of soybean extract in mice induced DSS can reduce expression of iNOS 
and β-catenin.
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